Recent advances in CRISPR/Cas9 technology for targeting latent HIV-1 reservoirs

Affiliations

Comment

Stacey C Tobin. AIDS. 2016.

. 2016 Jul 17;30(11):N17.

doi: 10.1097/QAD.0000000000001138.

No abstract available

Comment on

CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.
Zhang Y, Yin C, Zhang T, Li F, Yang W, Kaminski R, Fagan PR, Putatunda R, Young WB, Khalili K, Hu W. Zhang Y, et al. Sci Rep. 2015 Nov 5;5:16277. doi: 10.1038/srep16277. Sci Rep. 2015. PMID: 26538064 Free PMC article.
Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.
Ji H, Jiang Z, Lu P, Ma L, Li C, Pan H, Fu Z, Qu X, Wang P, Deng J, Yang X, Wang J, Zhu H. Ji H, et al. Mol Ther. 2016 Mar;24(3):508-21. doi: 10.1038/mt.2016.7. Epub 2016 Jan 18. Mol Ther. 2016. PMID: 26775808 Free PMC article.
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
Wang G, Zhao N, Berkhout B, Das AT. Wang G, et al. Mol Ther. 2016 Mar;24(3):522-6. doi: 10.1038/mt.2016.24. Epub 2016 Jan 22. Mol Ther. 2016. PMID: 26796669 Free PMC article.